ATRA: Atara Biotherapeutics Inc O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati
Atara Biotherapeutics innovatsion Ebvallo dorisini targ'ib qilmoqda va skleroz uchun hujayraviy terapiyani ishlab chiqmoqda. PEG koeffitsiyenti tendentsiyasi investitsiya jozibadorligini tasdiqlaydi, bunda 0.00 ko'rsatkichning joriy qiymatini aks ettiradi. Yevropalik hamkorlardan kapitalning barqaror kirimi tadqiqot va ishlanmalar (R&D) xarajatlarini to'liq qoplaydi. Shu bilan birga, ichki restrukturizatsiya va so'nggi bosqichdagi sinovlarga e'tibor qaratish biznesni tashqi makroiqtisodiy zarbalardan himoya qiladi.
Atara Biotherapeutics (ATRA) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- kompaniyaning balans qiymati tafsilotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati Atara Biotherapeutics|ATRA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati ko'rsatkichi atarabio.com|ATRA - Kompaniyaning jamlangan qarzlari|Balans qiymatiga qarzlar Atara Biotherapeutics Inc|ATRA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Atara Biotherapeutics|Oraliq likvidlik koeffitsiyenti atarabio.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
ATRA - Sof foyda|Prognoz qilingan kelajakdagi foyda Atara Biotherapeutics|ATRA - Narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori atarabio.com|ATRA - PEG multiplikatori|EV/EBITDA multiplikatori Atara Biotherapeutics Inc|ATRA - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda Atara Biotherapeutics|ATRA - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi atarabio.com|ATRA - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun foyda o'sishining konsensus prognozi Atara Biotherapeutics
Kompaniyaning umumiy tahlili:ATRA - Atara Biotherapeutics, Inc.
Aktivlarning operatsion barqarorligini baholash bozor qiymati va foyda o'sish sur'atlari orasidagi nisbat tahlilini talab qiladi. Atara Biotherapeutics (ATRA) uchun Yevropa Ittifoqidagi noyob terapiyasining premium maqomi cheklangan talabga duch kelmoqda. P/E o'sish tendentsiyasi bozor kapitalizatsiyasini daromadlar kengayish tezligi bilan solishtiradi. Bir birlikdan past qiymat biznesning o'z salohiyatiga nisbatan past baholanganini anglatadi. Grafikdagi keskin tebranishlar marjalarning pasayish xavflari haqida signal beradi.
Raqobatdosh kompaniyalar
ARGX (argenx N.V.) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori BNTX (BioNTech Group)|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Abivax (ABVX)|ADMA - Narxning foydaga va o‘sish sur’atiga nisbati|protagonist-inc.com (PTGX) - Narx-foyda va o‘sish multiplikatori|Immunovant (IMVT) - Narxning foydaga va o‘sish sur’atiga nisbati|Narx-foyda va o‘sish multiplikatori Kiniksa Pharmaceuticals, Ltd.|Narx-foyda va o‘sish multiplikatori GRFS|PEG multiplikatori Adaptive Biotechnologies Inc.|Narxning foydaga va o‘sish sur’atiga nisbati Celldex Therapeutics (CLDX)|auriniapharma.com - O‘sishni hisobga olgan narx-foyda koeffitsiyenti|PEG multiplikatori BCRX (BioCryst Pharmaceuticals)|Vera Therapeutics Inc (VERA) - O‘sish sur’atiga tuzatilgan narx-foyda|Dianthus Pharma - PEG multiplikatori|PHVS - PEG multiplikatori|ABCL (abcellera.com) - Narx-foyda va o‘sish multiplikatori|TRML: Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PGEN (Precigen) - PEG multiplikatori|PEG multiplikatori Pharming Group NV|Narxning foydaga va o‘sish sur’atiga nisbati Nektar (NKTR)|UPB (Upstream Pharma) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ZBIO (Zenas Biopharma Inc)|PEG multiplikatori immunome.com IMNM|GOSS: Narx-foyda va o‘sish multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti KALV (KalVista Pharma)|SEPN: PEG multiplikatori|PVLA (Pieris Corp) - Narxning foydaga va o‘sish sur’atiga nisbati|SVRA (Savara Inc.) - PEG multiplikatori|rigel.com (RIGL) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati AnaptysBio (ANAB)|ATXS - O‘sish sur’atiga tuzatilgan narx-foyda|enGene Bio - Narx-foyda va o‘sish multiplikatori|Kompaniya qiymatining foyda o‘sish sur’atiga nisbati RAPT (rapt.com)|Aerovate - PEG multiplikatori|O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti ACRS (aclaristx.com)|KYTX: PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda Tiziana Life Sciences Ltd. (TLSA)|Narxning foydaga va o‘sish sur’atiga nisbati Cabaletta Bio, Inc|VTYX: O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori THTX|PEG multiplikatori avalotx.com (AVTX)|Narxning foydaga va o‘sish sur’atiga nisbati Eledon Pharmaceuticals, Inc. ELDN|AGEN (Agenus, Inc.) - Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati|Climb Bio, Inc. - PEG multiplikatori|O‘sish sur’atiga tuzatilgan narx-foyda zurabio.com|ATYR (aTyr Pharma, Inc.) - Narx-foyda va o‘sish multiplikatori|Adagene Inc. (ADAG) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori IMA|STTK (Shattuck Therapeutics) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|PEG multiplikatori EQ|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati connectbiopharm.com|PEG multiplikatori IMUX (Immunic)|IFRX - Narx-foyda va o‘sish multiplikatori|XFOR - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati Adicet Bio ACET|CELU: PEG multiplikatori|INmune Bio Corporation (INMB) - PEG multiplikatori|Narx-foyda va o‘sish multiplikatori BRNS|KZR (kezarlifesciences.com) - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics PLC) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|PEG multiplikatori ENLV (Enlivex Therapeutics Ltd.)|PEG multiplikatori Q32 Bio Inc QTTB|GOVX - Narxning foydaga va o‘sish sur’atiga nisbati|Kapitalizatsiyaning foyda va o‘sish sur’atiga nisbati EDSA|IBIO: PEG multiplikatori|Carisma Therapeutics Inc. - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|XTLB (XTL Biopharmaceuticals, Ltd.) - PEG multiplikatori|PEG multiplikatori Bolt Bio|Narxning foydaga va o‘sish sur’atiga nisbati HCW Biologics Inc. (HCWB)|APVO (aptevotherapeutics.com) - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|Narxning foydaga va o‘sish sur’atiga nisbati AIM ImmunoTech AIM|ADTX - Narx-foyda va o‘sish multiplikatori|GRI Bio Corp - PEG multiplikatori|XRTX - PEG multiplikatori|HIND (Vyome Holdings Inc) - Narx-foyda va o‘sish multiplikatori|revbiosciences.com - O‘sish sur’atini hisobga olgan qoplash koeffitsiyenti|INDP (Indaptus Therapeutics, Inc.) - PEG multiplikatori|Scinai Immunotherapeutics Ltd (SCNI) - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga va o‘sish sur’atiga nisbati CalciMedica, Inc. (CALI)|Narx-foyda va o‘sish multiplikatori affimed.com AFMD|Narxning foydaga va o‘sish sur’atiga nisbati Allakos ALLK|HOOK - Narx-foyda va o‘sish multiplikatori|IGMS: Narx-foyda va o‘sish multiplikatori|ITOS - PEG multiplikatori|Ocean Bio (OCEA) - Narxning foydaga va o‘sish sur’atiga nisbati|O‘sishni hisobga olgan narx-foyda koeffitsiyenti TCBP|THRD (Third Harmonic Bio) - PEG multiplikatori
